Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_assertion type Assertion NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_head.
- NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_assertion description "[Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_provenance.
- NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_assertion evidence source_evidence_literature NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_provenance.
- NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_assertion SIO_000772 16938516 NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_provenance.
- NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_assertion wasDerivedFrom befree-20150227 NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_provenance.
- NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_assertion wasGeneratedBy ECO_0000203 NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_provenance.